利用异性CD4+ T细胞来重振宿主内源性抗瘤免疫力
1Department of Pediatric Oncology, Fukushima Medical University Hospital.
Fukushima journal of medical science
|October 25, 2023
概括
免疫检查点封锁 (ICB) 对晚期癌症有希望,但反应率不足. 新的策略,如使用捐赠细胞的"异构效应",可以增强抗瘤免疫力,提高癌症免疫疗法的疗效.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 细胞疗法细胞疗法
背景情况:
- 免疫检查点阻塞 (ICB) 疗法是晚期癌症的有希望的方法,但响应率仍然不足.
- 全基性造血干细胞移植 (HSCT) 显示出由供体淋巴细胞介导的强有力的移植对抗瘤 (GVT) 效应.
- "异质效应"描述了异质细胞诱导内源性抗瘤免疫,即使没有HSCT.
结论:
- 异构细胞,特别是CD4+T细胞,是增强癌症免疫疗法的宝贵工具.
- 通过全原效应诱导内源性抗瘤免疫力可以提高治疗疗效.
- 对于晚期癌症,需要进一步研究基于细胞的全基因策略.
相关概念视频
Tumor Immunotherapy
538
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
538
Cell-mediated Immune Responses
68.6K
Overview
68.6K


